Yakeel T Quiroz1,2, Kim Celone Willment3, Gabriel Castrillon4, Martha Muniz5, Francisco Lopera1, Andrew Budson6, Chantal E Stern5,7. 1. Grupo de Neurociencias, Universidad de Antioquia, Medellín, Colombia. 2. Departments of Psychiatry and Neurology, Massachusetts General Hospital, Boston, MA, USA. 3. Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA. 4. Instituto de Alta Tecnología Médica - IATM, Medellín, Colombia. 5. Center for Memory and Brain, Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA. 6. VA Boston Healthcare System and Boston University School of Medicine, Boston, MA, USA. 7. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, USA.
Abstract
BACKGROUND: Brain regions critical to episodic memory are altered during the preclinical stages of Alzheimer's disease (AD). However, reliable means of identifying cognitively-normal individuals at higher risk to develop AD have not been established. OBJECTIVE: To examine whether functional MRI can detect early functional changes associated with scene encoding in a group of presymptomatic presenilin-1 (PSEN1) E280A mutation carriers. METHODS: Participants were 39 young, cognitively-normal individuals from an autosomal dominant early-onset AD kindred, located in Antioquia, Colombia. Participants performed a functional MRI scene encoding task and a post-scan subsequent memory test. RESULTS: PSEN1 mutation carriers exhibited hyperactivation within medial temporal lobe regions (hippocampus,parahippocampal formation) during successful scene encoding compared to age-matched non-carriers. CONCLUSION: Hyperactivation in medial temporal lobe regions during scene encoding is seen in individuals genetically-determined to develop AD years before their clinical onset. Our findings will guide future research with the ultimate goal of using functional neuroimaging in the early detection of preclinical AD.
BACKGROUND: Brain regions critical to episodic memory are altered during the preclinical stages of Alzheimer's disease (AD). However, reliable means of identifying cognitively-normal individuals at higher risk to develop AD have not been established. OBJECTIVE: To examine whether functional MRI can detect early functional changes associated with scene encoding in a group of presymptomatic presenilin-1 (PSEN1) E280A mutation carriers. METHODS:Participants were 39 young, cognitively-normal individuals from an autosomal dominant early-onset AD kindred, located in Antioquia, Colombia. Participants performed a functional MRI scene encoding task and a post-scan subsequent memory test. RESULTS:PSEN1 mutation carriers exhibited hyperactivation within medial temporal lobe regions (hippocampus,parahippocampal formation) during successful scene encoding compared to age-matched non-carriers. CONCLUSION: Hyperactivation in medial temporal lobe regions during scene encoding is seen in individuals genetically-determined to develop AD years before their clinical onset. Our findings will guide future research with the ultimate goal of using functional neuroimaging in the early detection of preclinical AD.
Authors: David Prvulovic; Vincent Van de Ven; Alexander T Sack; Konrad Maurer; David E J Linden Journal: Psychiatry Res Date: 2005-11-30 Impact factor: 3.222
Authors: Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling Journal: J Neurosci Date: 2006-10-04 Impact factor: 6.167
Authors: N Filippini; K P Ebmeier; B J MacIntosh; A J Trachtenberg; G B Frisoni; G K Wilcock; C F Beckmann; S M Smith; P M Matthews; C E Mackay Journal: Neuroimage Date: 2010-08-10 Impact factor: 6.556
Authors: Natalia Acosta-Baena; Diego Sepulveda-Falla; Carlos Mario Lopera-Gómez; Mario César Jaramillo-Elorza; Sonia Moreno; Daniel Camilo Aguirre-Acevedo; Amanda Saldarriaga; Francisco Lopera Journal: Lancet Neurol Date: 2011-02-04 Impact factor: 44.182
Authors: Michele L Ries; Cynthia M Carlsson; Howard A Rowley; Mark A Sager; Carey E Gleason; Sanjay Asthana; Sterling C Johnson Journal: J Am Geriatr Soc Date: 2008-04-09 Impact factor: 5.562
Authors: Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson Journal: Neuron Date: 2009-07-30 Impact factor: 17.173
Authors: Adam S Fleisher; Kewei Chen; Yakeel T Quiroz; Laura J Jakimovich; Madelyn Gutierrez Gomez; Carolyn M Langois; Jessica B S Langbaum; Napatkamon Ayutyanont; Auttawut Roontiva; Pradeep Thiyyagura; Wendy Lee; Hua Mo; Liliana Lopez; Sonia Moreno; Natalia Acosta-Baena; Margarita Giraldo; Gloria Garcia; Rebecca A Reiman; Matthew J Huentelman; Kenneth S Kosik; Pierre N Tariot; Francisco Lopera; Eric M Reiman Journal: Lancet Neurol Date: 2012-11-06 Impact factor: 44.182
Authors: D C Aguirre-Acevedo; R D Gómez; S Moreno; E Henao-Arboleda; M Motta; C Muñoz; A Arana; D A Pineda; F Lopera Journal: Rev Neurol Date: 2007 Dec 1-15 Impact factor: 0.870
Authors: J T Fuller; A Cronin-Golomb; J R Gatchel; D J Norton; E Guzmán-Vélez; H I L Jacobs; B Hanseeuw; E Pardilla-Delgado; A Artola; A Baena; Y Bocanegra; K S Kosik; K Chen; P N Tariot; K Johnson; R A Sperling; E M Reiman; F Lopera; Y T Quiroz Journal: J Prev Alzheimers Dis Date: 2019
Authors: John Fredy Ochoa; Joan Francesc Alonso; Jon Edinson Duque; Carlos Andrés Tobón; Miguel Angel Mañanas; Francisco Lopera; Alher Mauricio Hernández Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472